VCYT
Veracyte Inc
NASDAQ: VCYT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$31.78
-4.94% today
Updated 2026-04-29
Market cap
$2.67B
P/E ratio
40.77
P/S ratio
5.16x
EPS (TTM)
$0.82
Dividend yield
—
52W range
$23 – $51
Volume
0.9M
Veracyte Inc (VCYT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.65M | $11.63M | $21.88M | $38.19M | $49.50M | $65.08M | $71.95M | $92.01M | $120.37M | $117.48M | $219.51M | $296.54M | $361.05M | $445.76M | $517.14M |
| Revenue growth (YoY) | — | +339.6% | +88.2% | +74.5% | +29.6% | +31.5% | +10.6% | +27.9% | +30.8% | -2.4% | +86.8% | +35.1% | +21.8% | +23.5% | +16.0% |
| Cost of revenue | $2.92M | $7.58M | $12.61M | $16.61M | $21.50M | $25.46M | $28.20M | $33.08M | $36.52M | $41.45M | $74.40M | $101.58M | $112.90M | $147.62M | $157.10M |
| Gross profit | $-280000.00 | $4.04M | $9.28M | $21.58M | $28.01M | $39.62M | $43.76M | $58.93M | $83.84M | $76.03M | $145.11M | $194.95M | $248.15M | $298.14M | $360.05M |
| Gross margin | -10.6% | 34.8% | 42.4% | 56.5% | 56.6% | 60.9% | 60.8% | 64.0% | 69.7% | 64.7% | 66.1% | 65.7% | 68.7% | 66.9% | 69.6% |
| R&D | $6.68M | $6.61M | $7.81M | $9.80M | $12.80M | $15.32M | $13.88M | $14.82M | $14.85M | $17.20M | $29.84M | $40.60M | $57.30M | $69.29M | $70.81M |
| SG&A | $5.37M | $7.92M | $12.10M | $18.85M | $22.58M | $23.79M | $23.09M | $23.96M | $29.03M | $36.73M | $101.35M | $76.52M | $157.63M | $178.27M | $110.78M |
| Operating income | $-15.27M | $-18.93M | $-23.17M | $-29.01M | $-33.47M | $-28.80M | $-26.54M | $-22.23M | $-15.13M | $-35.39M | $-81.90M | $-41.08M | $-85.80M | $16.14M | $74.15M |
| Operating margin | -577.2% | -162.8% | -105.9% | -76.0% | -67.6% | -44.3% | -36.9% | -24.2% | -12.6% | -30.1% | -37.3% | -13.9% | -23.8% | 3.6% | 14.3% |
| EBITDA | $-13.83M | $-17.94M | $-24.35M | $-28.93M | $-32.53M | $-25.09M | $-23.76M | $-17.12M | $-7.80M | $-26.74M | $-60.18M | $-6.98M | $-49.41M | $49.20M | $89.62M |
| EBITDA margin | -523.0% | -154.3% | -111.3% | -75.8% | -65.7% | -38.5% | -33.0% | -18.6% | -6.5% | -22.8% | -27.4% | -2.4% | -13.7% | 11.0% | 17.3% |
| EBIT | $-14.45M | $-18.65M | $-25.35M | $-30.11M | $-33.33M | $-28.60M | $-27.61M | $-21.04M | $-11.92M | $-34.68M | $-81.41M | $-36.23M | $-76.60M | $25.75M | $68.20M |
| Interest expense | $0.00 | $0.00 | $233000.00 | $439000.00 | $378000.00 | $2.76M | $4.94M | $1.96M | $677000.00 | $229000.00 | $241000.00 | $198000.00 | $15000.00 | $2000.00 | $1000.00 |
| Income tax | $819000.00 | $-2000.00 | $-2.94M | $-664000.00 | $518000.00 | $2.96M | $5.42M | $1.20M | $3.88M | $938000.00 | $-6.09M | $133000.00 | $-2.21M | $1.61M | — |
| Effective tax rate | -6.0% | 0.0% | 10.3% | 2.2% | -1.6% | -10.4% | -21.2% | -5.5% | -44.5% | -2.8% | 7.5% | -0.4% | 2.9% | 6.2% | 0.0% |
| Net income | $-14.45M | $-18.65M | $-25.58M | $-29.37M | $-33.70M | $-31.36M | $-31.00M | $-23.00M | $-12.60M | $-34.91M | $-75.56M | $-36.56M | $-74.40M | $24.14M | $66.35M |
| Net income growth (YoY) | — | -29.1% | -37.2% | -14.8% | -14.7% | +7.0% | +1.1% | +25.8% | +45.2% | -177.1% | -116.5% | +51.6% | -103.5% | +132.4% | +174.9% |
| Profit margin | -546.1% | -160.4% | -116.9% | -76.9% | -68.1% | -48.2% | -43.1% | -25.0% | -10.5% | -29.7% | -34.4% | -12.3% | -20.6% | 5.4% | 12.8% |